Company intelligence / Profile preview
Hangzhou Tianji Jishi Biotechnology
- Ownership
- Private
- Development stage
- Other
Overview
Hangzhou Tianji Jishi Biotechnology is a private Chinese biotech founded in August 2021 focused on advancing mitochondrial research through novel small molecule mitophagy inducers. Their lead candidate, TJ0113, has reached phase 2 clinical trials for depressive disorder and Parkinson’s disease and earlier stages for several other neurological and metabolic conditions. The company aims to become a leader in innovative biopharmaceuticals targeting diseases with unmet needs related to mitochondrial dysfunction. No published clinical results as of June 2025.
- Therapeutic areas
- NephrologyPsychiatryNeurologyCardiovascular
- Modalities
- Small moleculeMitophagy inducers
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Hangzhou Tianji Jishi Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hangzhou Tianji Jishi Biotechnology.